简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:BENGALURU, Nov 6 (Reuters) - Indian consumer good company Zydus Wellness (ZYDS.NS) reported a more t
BENGALURU, Nov 6 (Reuters) - Indian consumer good company Zydus Wellness (ZYDS.NS) reported a more than 30% drop in second-quarter net profit on Monday due to a one-off deferred tax expense.
The maker of Glucon-D energy drink and Complan health drink, posted a net profit of 59 million rupees ($709,134.62) for the quarter ended Sept. 30, as it flagged a deferred tax of 27 million rupees.
However, it reported a 4.9% rise in profit excluding tax expenses at 86 million rupees.
Analysts had expected gross margins for most consumer good companies to expand year-on-year during the July-September quarter due to a moderation in prices of some raw materials.
The Ahmedabad-based company said its raw materials cost, which includes commodities such as milk, refined palm oil and aspartame, dropped 13.2% to 1.82 billion rupees.
\“Commodity rates continues to moderate sequentially during the quarter,\” said the company, in which generic drugmaker Zydus Lifesciences (ZYDU.NS) holds a 58% stake.
Sales marginally rose 2.6% to 4.38 billion rupees due to slow demand recovery in rural markets, which was disrupted by the delayed and erratic monsoon this year.
Zydus added that it made calibrated price hikes across its portfolio to improve gross margins. Gross margin on net sales for the quarter was at 44.9%, 198 basis points higher than a year ago.
Bigger rivals Nestle India (NEST.NS) and Dabur India (DABU.NS) beat September quarter profit estimates on higher demand, while ITC (ITC.NS) missed profit view as it grappled with stiff competition.
Zydus shares dropped immediately after the results but recovered losses and were trading 2% higher at 1576.7 rupees as of 13:05 p.m. IST.
($1 = 83.2000 Indian rupees)
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.